KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Convertible Debt (2020 - 2025)

Neogenomics' Convertible Debt history spans 6 years, with the latest figure at $341.9 million for Q4 2025.

  • For Q4 2025, Convertible Debt changed 0.45% year-over-year to $341.9 million; the TTM value through Dec 2025 reached $341.9 million, changed 0.45%, while the annual FY2025 figure was $341.9 million, 0.45% changed from the prior year.
  • Convertible Debt reached $341.9 million in Q4 2025 per NEO's latest filing, roughly flat from $341.5 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $538.9 million in Q1 2024 to a low of $339.6 million in Q2 2024.
  • Average Convertible Debt over 5 years is $466.8 million, with a median of $532.1 million recorded in 2021.
  • Peak YoY movement for Convertible Debt: skyrocketed 222.76% in 2021, then tumbled 36.78% in 2025.
  • A 5-year view of Convertible Debt shows it stood at $532.5 million in 2021, then grew by 0.53% to $535.3 million in 2022, then rose by 0.54% to $538.2 million in 2023, then crashed by 36.76% to $340.3 million in 2024, then rose by 0.45% to $341.9 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Convertible Debt are $341.9 million (Q4 2025), $341.5 million (Q3 2025), and $341.1 million (Q2 2025).